{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,7]],"date-time":"2026-09-07T14:21:40Z","timestamp":1788790900828,"version":"build-2803163510"},"reference-count":100,"publisher":"Elsevier BV","issue":"11","license":[{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100017584","name":"SRMIST","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100017584","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Current Problems in Cardiology"],"published-print":{"date-parts":[[2026,11]]},"DOI":"10.1016\/j.cpcardiol.2026.103422","type":"journal-article","created":{"date-parts":[[2026,8,12]],"date-time":"2026-08-12T15:09:42Z","timestamp":1786547382000},"page":"103422","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Pharmacogenomic and drug interactions risk in cardio-oncology: A precision medicine perspective for India"],"prefix":"10.1016","volume":"51","author":[{"given":"Aanya","family":"Verma","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Priya","family":"D","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"15","key":"10.1016\/j.cpcardiol.2026.103422_bib0001","doi-asserted-by":"crossref","first-page":"E811","DOI":"10.1161\/CIR.0000000000001056","article-title":"Cardio-oncology drug interactions: a scientific statement from the american heart association","volume":"145","author":"Beavers","year":"2022","journal-title":"Circulation"},{"key":"10.1016\/j.cpcardiol.2026.103422_bib0002","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1016\/j.thromres.2020.08.016","article-title":"Drug-drug interactions with direct oral anticoagulants associated with adverse events in the real world: a systematic review","volume":"194","author":"Li","year":"2020","journal-title":"Thromb Res"},{"issue":"6","key":"10.1016\/j.cpcardiol.2026.103422_bib0003","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1007\/s11897-020-00485-9","article-title":"The complex management of atrial fibrillation and cancer in the COVID-19 era: drug interactions, thromboembolic risk, and proarrhythmia","volume":"17","author":"Gatti","year":"2020","journal-title":"Curr Heart Fail Rep"},{"issue":"1","key":"10.1016\/j.cpcardiol.2026.103422_bib0004","doi-asserted-by":"crossref","DOI":"10.1186\/s12885-022-09649-3","article-title":"A comprehensive evaluation of potentially significant drug-drug, drug-herb, and drug-food interactions among cancer patients receiving anticancer drugs","volume":"22","author":"Koni","year":"2022","journal-title":"BMC Cancer"},{"issue":"5","key":"10.1016\/j.cpcardiol.2026.103422_bib0005","doi-asserted-by":"crossref","first-page":"2251","DOI":"10.18203\/2319-2003.ijbcp20163270","article-title":"Potential drug-drug interactions among hospitalized cardiac patients","volume":"5","author":"Shanbhag","year":"2016","journal-title":"Int J Basic Clin Pharmacol"},{"issue":"4","key":"10.1016\/j.cpcardiol.2026.103422_bib0006","first-page":"785","article-title":"Investigate how genetic variations impact drug response and explore the integration of pharmacogenomics into clinical practice","volume":"13","author":"TumkurSattar","year":"2023","journal-title":"Eur J Cardiovasc Med [Internet]"},{"issue":"5","key":"10.1016\/j.cpcardiol.2026.103422_bib0007","doi-asserted-by":"crossref","first-page":"149","DOI":"10.14740\/wjon1405","article-title":"Genetic Polymorphisms in Pharmaceuticals and Chemotherapy","volume":"12","author":"Gummadi","year":"2021","journal-title":"World J Oncol"},{"issue":"R2","key":"10.1016\/j.cpcardiol.2026.103422_bib0008","doi-asserted-by":"crossref","first-page":"R177","DOI":"10.1093\/hmg\/ddaa134","article-title":"Pharmacogenomics meets precision cardio-oncology: is there synergistic potential?","volume":"29","author":"Hockings","year":"2020","journal-title":"Hum Mol Genet"},{"issue":"1","key":"10.1016\/j.cpcardiol.2026.103422_bib0009","first-page":"17","article-title":"Pharmacogenetics: implementing personalized medicine","volume":"6","author":"Mini","year":"2009","journal-title":"Clin Cases Miner Bone Metab"},{"key":"10.1016\/j.cpcardiol.2026.103422_bib0010","doi-asserted-by":"crossref","DOI":"10.6061\/clinics\/2017\/e723","article-title":"Precision Medicine: Changing the way we think about healthcare","volume":"73","author":"Gameiro","year":"2018","journal-title":"Clinics"},{"key":"10.1016\/j.cpcardiol.2026.103422_bib0011","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1146\/annurev-statistics-030718-105251","article-title":"Precision Medicine","volume":"6","author":"Kosorok","year":"2019","journal-title":"Annu Rev Stat Appl"},{"key":"10.1016\/j.cpcardiol.2026.103422_bib0012","first-page":"332","article-title":"Advancing Precision Medicine: A Review of Innovative In Silico Approaches for Drug Development, Clinical Pharmacology and Personalized Healthcare","volume":"16","author":"Marques","year":"2024","journal-title":"Pharm 2024"},{"issue":"5","key":"10.1016\/j.cpcardiol.2026.103422_bib0013","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1016\/j.gpb.2016.03.008","article-title":"Pharmacogenomics of Drug Metabolizing Enzymes and Transporters: Relevance to Precision Medicine","volume":"14","author":"Ahmed","year":"2016","journal-title":"Genom Proteom Bioinform"},{"key":"10.1016\/j.cpcardiol.2026.103422_bib0014","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2023.1189976","article-title":"Pharmacogenomics in practice: a review and implementation guide","volume":"14","author":"Kabbani","year":"2023","journal-title":"Front Pharmacol"},{"issue":"9","key":"10.1016\/j.cpcardiol.2026.103422_bib0015","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1038\/nrg.2016.86","article-title":"Towards precision medicine","volume":"17","author":"Ashley","year":"2016","journal-title":"Nat Rev Genet"},{"issue":"4","key":"10.1016\/j.cpcardiol.2026.103422_bib0016","doi-asserted-by":"crossref","first-page":"933","DOI":"10.13005\/ojc\/400403","article-title":"Personalized medicine: (a comprehensive review)","volume":"40","author":"Pandey","year":"2024","journal-title":"Orient J Chem"},{"key":"10.1016\/j.cpcardiol.2026.103422_bib0017","doi-asserted-by":"crossref","DOI":"10.3389\/fmed.2024.1365524","article-title":"Personalized anesthesia and precision medicine: a comprehensive review of genetic factors, artificial intelligence, and patient-specific factors","volume":"11","author":"Zeng","year":"2024","journal-title":"Front Med"},{"issue":"1","key":"10.1016\/j.cpcardiol.2026.103422_bib0018","first-page":"920","article-title":"Implementing community-engaged pharmacogenomics in Indigenous communities","volume":"15","author":"Claw","year":"2024","journal-title":"Nat Commun 2024 15:1"},{"issue":"7","key":"10.1016\/j.cpcardiol.2026.103422_bib0019","doi-asserted-by":"crossref","DOI":"10.1016\/j.bbadis.2024.167339","article-title":"Advancing personalized medicine: Integrating statistical algorithms with omics and nano-omics for enhanced diagnostic accuracy and treatment efficacy","volume":"1870","author":"Coskun","year":"2024","journal-title":"Biochim Biophys Acta (BBA) - Mol Basis Dis"},{"issue":"2","key":"10.1016\/j.cpcardiol.2026.103422_bib0020","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1111\/jdv.13854","article-title":"A systematic review of worldwide epidemiology of psoriasis","volume":"31","author":"Michalek","year":"2017","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"10.1016\/j.cpcardiol.2026.103422_bib0021","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1146\/annurev-pharmtox-010510-100502","article-title":"Omics and drug response","volume":"53","author":"Meyer","year":"2013","journal-title":"Annu Rev Pharmacol Toxicol"},{"key":"10.1016\/j.cpcardiol.2026.103422_bib0022","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1007\/978-981-10-5717-5_8","article-title":"Interactions Between Genetics, Lifestyle, and Environmental Factors for Healthcare","volume":"1005","author":"Lin","year":"2017","journal-title":"Adv Exp Med Biol"},{"issue":"21","key":"10.1016\/j.cpcardiol.2026.103422_bib0023","doi-asserted-by":"crossref","first-page":"2211","DOI":"10.1056\/NEJMra032424","article-title":"Drug metabolism and variability among patients in drug response","volume":"352","author":"Wilkinson","year":"2005","journal-title":"N Engl J Med"},{"issue":"6","key":"10.1016\/j.cpcardiol.2026.103422_bib0024","doi-asserted-by":"crossref","first-page":"538","DOI":"10.1056\/NEJMra020526","article-title":"Pharmacogenomics\u2013drug disposition, drug targets, and side effects","volume":"348","author":"Evans","year":"2003","journal-title":"N Engl J Med"},{"issue":"4","key":"10.1016\/j.cpcardiol.2026.103422_bib0025","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1124\/mi.6.4.8","article-title":"The pharmocogenomics of warfarin: closing in on personalized medicine","volume":"6","author":"Rettie","year":"2006","journal-title":"Mol Interv"},{"issue":"1","key":"10.1016\/j.cpcardiol.2026.103422_bib0026","first-page":"11","article-title":"Pharmacogenomics of drug metabolizing enzymes and transporters: implications for cancer therapy","volume":"4","author":"Li","year":"2011","journal-title":"Pharmgenomics Pers Med"},{"key":"10.1016\/j.cpcardiol.2026.103422_bib0027","doi-asserted-by":"crossref","unstructured":"Ul N, Mohsin A, Farrukh M, Shahzadi S, Irfan M Drug metabolism: phase i and phase ii metabolic pathways [internet]. 2024 Feb 14. doi:10.5772\/INTECHOPEN.112854.","DOI":"10.5772\/intechopen.112854"},{"issue":"5439","key":"10.1016\/j.cpcardiol.2026.103422_bib0028","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1126\/science.286.5439.487","article-title":"Pharmacogenomics: translating functional genomics into rational therapeutics","volume":"286","author":"Evans","year":"1999","journal-title":"Science"},{"issue":"5","key":"10.1016\/j.cpcardiol.2026.103422_bib0029","first-page":"467","article-title":"Personalized medicine: going to the dogs?","volume":"138","author":"Mealey","year":"2019","journal-title":"Hum Genet 2019 138:5"},{"issue":"4","key":"10.1016\/j.cpcardiol.2026.103422_bib0030","doi-asserted-by":"crossref","DOI":"10.4155\/fso.15.80","article-title":"Pharmacogenetics of cancer therapy: breakthroughs from beyond?","volume":"1","author":"Lu","year":"2015","journal-title":"Future Sci OA"},{"issue":"1","key":"10.1016\/j.cpcardiol.2026.103422_bib0031","first-page":"175","article-title":"Exploring treatment options in cancer: tumor treatment strategies","volume":"9","author":"Liu","year":"2024","journal-title":"Signal Transduct Target Ther 2024 9:1"},{"key":"10.1016\/j.cpcardiol.2026.103422_bib0032","doi-asserted-by":"crossref","unstructured":"Franczyk B, Rysz J, Gluba-Brz\u00f3zka A Pharmacogenetics of drugs used in the treatment of cancers. genes (basel). 2022 Feb 1;13(2). doi:10.3390\/GENES13020311 PubMed PMID: 35205356.","DOI":"10.3390\/genes13020311"},{"issue":"11","key":"10.1016\/j.cpcardiol.2026.103422_bib0033","doi-asserted-by":"crossref","first-page":"1639","DOI":"10.1038\/sj.onc.1209373","article-title":"Glutathione S-transferase polymorphisms: cancer incidence and therapy","volume":"25","author":"McIlwain","year":"2006","journal-title":"Oncogene"},{"issue":"4","key":"10.1016\/j.cpcardiol.2026.103422_bib0034","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1016\/j.coph.2007.06.009","article-title":"Genetic polymorphism and function of glutathione S-transferases in tumor drug resistance","volume":"7","author":"Lo","year":"2007","journal-title":"Curr Opin Pharmacol"},{"issue":"2","key":"10.1016\/j.cpcardiol.2026.103422_bib0035","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1053\/j.seminoncol.2011.01.005","article-title":"The use of genomic information to optimize cancer chemotherapy","volume":"38","author":"Innocenti","year":"2011","journal-title":"Semin Oncol"},{"issue":"2","key":"10.1016\/j.cpcardiol.2026.103422_bib0036","doi-asserted-by":"crossref","first-page":"155","DOI":"10.2174\/138161210790112719","article-title":"Pharmacogenetics in oncology: a promising field","volume":"16","author":"Houtsma","year":"2009","journal-title":"Curr Pharm Des"},{"key":"10.1016\/j.cpcardiol.2026.103422_bib0037","doi-asserted-by":"crossref","first-page":"877","DOI":"10.1016\/j.phrs.2016.08.002","article-title":"Pharmacogenetic predictors of toxicity to platinum based chemotherapy in non-small cell lung cancer patients","volume":"111","author":"P\u00e9rez-Ram\u00edrez","year":"2016","journal-title":"Pharmacol Res"},{"issue":"2","key":"10.1016\/j.cpcardiol.2026.103422_bib0038","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1002\/cpt.911","article-title":"Clinical Pharmacogenetics implementation consortium (cpic) guideline for dihydropyrimidine dehydrogenase genotype and fluoropyrimidine dosing: 2017 update","volume":"103","author":"Amstutz","year":"2018","journal-title":"Clin Pharmacol Ther"},{"issue":"11","key":"10.1016\/j.cpcardiol.2026.103422_bib0039","doi-asserted-by":"crossref","first-page":"2895","DOI":"10.1158\/1535-7163.MCT-06-0327","article-title":"Clinical relevance of different dihydropyrimidine dehydrogenase gene single nucleotide polymorphisms on 5-fluorouracil tolerance","volume":"5","author":"Morel","year":"2006","journal-title":"Mol Cancer Ther"},{"issue":"3","key":"10.1016\/j.cpcardiol.2026.103422_bib0040","doi-asserted-by":"crossref","first-page":"610","DOI":"10.1172\/JCI118830","article-title":"Molecular basis of the human dihydropyrimidine dehydrogenase deficiency and 5-fluorouracil toxicity","volume":"98","author":"Wei","year":"1996","journal-title":"J Clin Invest"},{"issue":"8","key":"10.1016\/j.cpcardiol.2026.103422_bib0041","doi-asserted-by":"crossref","first-page":"1382","DOI":"10.1200\/JCO.2004.07.173","article-title":"Genetic variants in the UDP-glucuronosyltransferase 1A1 gene predict the risk of severe neutropenia of irinotecan","volume":"22","author":"Innocenti","year":"2004","journal-title":"J Clin Oncol"},{"issue":"1","key":"10.1016\/j.cpcardiol.2026.103422_bib0042","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1038\/sj.tpj.6500072","article-title":"UGT1A1*28 polymorphism as a determinant of irinotecan disposition and toxicity","volume":"2","author":"Iyer","year":"2002","journal-title":"Pharmacogenomics J"},{"issue":"15","key":"10.1016\/j.cpcardiol.2026.103422_bib0043","doi-asserted-by":"crossref","first-page":"2237","DOI":"10.1200\/JCO.2005.03.0239","article-title":"Comprehensive analysis of UGT1A polymorphisms predictive for pharmacokinetics and treatment outcome in patients with non-small-cell lung cancer treated with irinotecan and cisplatin","volume":"24","author":"Han","year":"2006","journal-title":"J Clin Oncol"},{"issue":"1","key":"10.1016\/j.cpcardiol.2026.103422_bib0044","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1038\/bjc.2011.206","article-title":"A genotype-directed phase I-IV dose-finding study of irinotecan in combination with fluorouracil\/leucovorin as first-line treatment in advanced colorectal cancer","volume":"105","author":"Marcuello","year":"2011","journal-title":"Br J Cancer"},{"issue":"8","key":"10.1016\/j.cpcardiol.2026.103422_bib0045","doi-asserted-by":"crossref","first-page":"2293","DOI":"10.1200\/JCO.2001.19.8.2293","article-title":"Preponderance of thiopurine s-methyltransferase deficiency and heterozygosity among patients intolerant to mercaptopurine or azathioprine","volume":"19","author":"Evans","year":"2001","journal-title":"J Clin Oncol"},{"issue":"4","key":"10.1016\/j.cpcardiol.2026.103422_bib0046","first-page":"483","article-title":"Results of a phase II clinical trial of 6-mercaptopurine (6MP) and methotrexate in patients with BRCA-defective tumours","volume":"122","author":"Roberts","year":"2020","journal-title":"Br J Cancer 2019 122:4"},{"key":"10.1016\/j.cpcardiol.2026.103422_bib0047","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1016\/j.ejphar.2014.07.025","article-title":"Cisplatin in cancer therapy: molecular mechanisms of action","volume":"740","author":"Dasari","year":"2014","journal-title":"Eur J Pharmacol"},{"issue":"2","key":"10.1016\/j.cpcardiol.2026.103422_bib0048","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/j.jaccao.2024.02.001","article-title":"Cardiovascular concerns, cancer treatment, and biological and chronological aging in cancer: JACC family series","volume":"6","author":"Ioffe","year":"2024","journal-title":"JACC CardioOncol"},{"key":"10.1016\/j.cpcardiol.2026.103422_bib0049","doi-asserted-by":"crossref","unstructured":"Nemer G, Nafiz Hendi N Pharmacogenomics of cardiovascular diseases: the path to precision therapy [internet]. 2024 May 29. doi:10.5772\/INTECHOPEN.113236.","DOI":"10.5772\/intechopen.113236"},{"issue":"5","key":"10.1016\/j.cpcardiol.2026.103422_bib0050","doi-asserted-by":"crossref","first-page":"791","DOI":"10.1124\/pharmrev.123.000750","article-title":"Cardiovascular pharmacogenetics: from discovery of genetic association to clinical adoption of derived test","volume":"76","author":"Delabays","year":"2024","journal-title":"Pharmacol Rev"},{"issue":"1","key":"10.1016\/j.cpcardiol.2026.103422_bib0051","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1124\/dmd.109.029132","article-title":"Identification of the human cytochrome P450 enzymes involved in the two oxidative steps in the bioactivation of clopidogrel to its pharmacologically active metabolite","volume":"38","author":"Kazui","year":"2010","journal-title":"Drug Metab Dispos"},{"issue":"6974","key":"10.1016\/j.cpcardiol.2026.103422_bib0052","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1038\/nature02214","article-title":"Mutations in VKORC1 cause warfarin resistance and multiple coagulation factor deficiency type 2","volume":"427","author":"Rost","year":"2004","journal-title":"Nature"},{"issue":"2","key":"10.1016\/j.cpcardiol.2026.103422_bib0053","doi-asserted-by":"crossref","first-page":"187","DOI":"10.2174\/138161210790112737","article-title":"Pharmacogenetics of oral anticoagulant therapy","volume":"16","author":"Pop","year":"2010","journal-title":"Curr Pharm Des"},{"issue":"3","key":"10.1016\/j.cpcardiol.2026.103422_bib0054","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1097\/00008571-200204000-00010","article-title":"Cytochrome P450 2C9 polymorphisms: a comprehensive review of the in-vitro and human data","volume":"12","author":"Lee","year":"2002","journal-title":"Pharmacogenetics"},{"key":"10.1016\/j.cpcardiol.2026.103422_bib0055","doi-asserted-by":"crossref","unstructured":"Aftab Siddiqui M, Jain C, Usmani A, Hafeez A, Khalid M, Mujahid M. Pharmacogenetics and pharmacogenomics impact on aspirin response. 2024 May 29. doi:10.5772\/INTECHOPEN.113026.","DOI":"10.5772\/intechopen.113026"},{"issue":"1","key":"10.1016\/j.cpcardiol.2026.103422_bib0056","doi-asserted-by":"crossref","first-page":"51","DOI":"10.30872\/jsk.v6i1.636","article-title":"Profil aktivitas enzim alkaline phosphatase (alp), aspartate aminotransferase (ast), dan alanine transaminase (alt) pada tikus hiperlipidemia yang diberi madu fermentasi bawang tunggal","volume":"6","author":"Dyah Wulandari","year":"2025","journal-title":"J Sains dan Kesehat"},{"issue":"1","key":"10.1016\/j.cpcardiol.2026.103422_bib0057","first-page":"1","article-title":"Role of statins in coronary artery disease","volume":"49","author":"Nakagawa","year":"2013","journal-title":"Chonnam Med J"},{"issue":"6","key":"10.1016\/j.cpcardiol.2026.103422_bib0058","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1016\/j.amjcard.2005.09.134","article-title":"Phenotypic predictors of response to Simvastatin therapy among African-Americans and Caucasians: The cholesterol and pharmacogenetics (CAP) study","volume":"97","author":"Simon","year":"2006","journal-title":"Am J Cardiol"},{"issue":"6","key":"10.1016\/j.cpcardiol.2026.103422_bib0059","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1038\/sj.tpj.6500384","article-title":"Clinical implications of pharmacogenomics of statin treatment","volume":"6","author":"Mangravite","year":"2006","journal-title":"Pharmacogenomics J"},{"issue":"8A","key":"10.1016\/j.cpcardiol.2026.103422_bib0060","doi-asserted-by":"crossref","first-page":"S52","DOI":"10.1016\/j.amjcard.2005.12.010","article-title":"Statin safety: a systematic review","volume":"97","author":"Law","year":"2006","journal-title":"Am J Cardiol"},{"issue":"38","key":"10.1016\/j.cpcardiol.2026.103422_bib0061","doi-asserted-by":"crossref","first-page":"35669","DOI":"10.1074\/jbc.M103792200","article-title":"Polymorphisms in OATP-C: identification of multiple allelic variants associated with altered transport activity among European- and African-Americans","volume":"276","author":"Tirona","year":"2001","journal-title":"J Biol Chem"},{"issue":"1","key":"10.1016\/j.cpcardiol.2026.103422_bib0062","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1161\/STROKEAHA.122.037717","article-title":"Pharmacogenomics in stroke and cardiovascular disease: state of the art","volume":"54","author":"Ross","year":"2023","journal-title":"Stroke"},{"issue":"7","key":"10.1016\/j.cpcardiol.2026.103422_bib0063","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1007\/s11886-013-0376-0","article-title":"Pharmacogenomics and cardiovascular disease","volume":"15","author":"Weeke","year":"2013","journal-title":"Curr Cardiol Rep"},{"issue":"4","key":"10.1016\/j.cpcardiol.2026.103422_bib0064","doi-asserted-by":"crossref","first-page":"273","DOI":"10.4168\/aair.2011.3.4.273","article-title":"Polymorphisms of aspirin-metabolizing enzymes CYP2C9, NAT2 and UGT1A6 in aspirin-intolerant urticaria","volume":"3","author":"Palikhe","year":"2011","journal-title":"Allergy Asthma Immunol Res"},{"issue":"4","key":"10.1016\/j.cpcardiol.2026.103422_bib0065","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1586\/17512433.2014.910111","article-title":"Understanding and preventing drug-drug and drug-gene interactions","volume":"7","author":"Tannenbaum","year":"2014","journal-title":"Expert Rev Clin Pharmacol"},{"issue":"5","key":"10.1016\/j.cpcardiol.2026.103422_bib0066","doi-asserted-by":"crossref","first-page":"487","DOI":"10.3390\/ph14050487","article-title":"The Influence of pharmacogenetics on the clinical relevance of pharmacokinetic drug-drug interactions: drug-gene, drug-gene-gene and drug-drug-gene interactions","volume":"14","author":"Hahn","year":"2021","journal-title":"Pharmaceuticals"},{"issue":"8","key":"10.1016\/j.cpcardiol.2026.103422_bib0067","doi-asserted-by":"crossref","first-page":"863","DOI":"10.1007\/s11886-023-01906-6","article-title":"Cardio-oncology: shared genetic, metabolic, and pharmacologic mechanism","volume":"25","author":"Zhao","year":"2023","journal-title":"Curr Cardiol Rep"},{"issue":"2","key":"10.1016\/j.cpcardiol.2026.103422_bib0068","doi-asserted-by":"crossref","first-page":"604","DOI":"10.3390\/ijms21020604","article-title":"The role of CYP450 drug metabolism in precision cardio-oncology","volume":"21","author":"Fatunde","year":"2020","journal-title":"Int J Mol Sci"},{"issue":"4","key":"10.1016\/j.cpcardiol.2026.103422_bib0069","doi-asserted-by":"crossref","first-page":"443","DOI":"10.2967\/jnumed.118.220137","article-title":"Precision cardio-oncology","volume":"60","author":"Dreyfuss","year":"2019","journal-title":"J Nucl Med"},{"issue":"11","key":"10.1016\/j.cpcardiol.2026.103422_bib0070","doi-asserted-by":"crossref","first-page":"1333","DOI":"10.1042\/CS20200309","article-title":"Interactions between cardiology and oncology drugs in precision cardio-oncology","volume":"135","author":"Kamaraju","year":"2021","journal-title":"Clin Sci"},{"issue":"1","key":"10.1016\/j.cpcardiol.2026.103422_bib0071","first-page":"13","article-title":"5-FU induced cardiotoxicity: case series and review of the literature","volume":"5","author":"Yuan","year":"2019","journal-title":"Cardio-oncol"},{"issue":"12","key":"10.1016\/j.cpcardiol.2026.103422_bib0072","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0188740","article-title":"Clopidogrel in a combined therapy with anticancer drugs-effect on tumor growth, metastasis, and treatment toxicity: studies in animal models","volume":"12","author":"Denslow","year":"2017","journal-title":"PLoS One"},{"issue":"4","key":"10.1016\/j.cpcardiol.2026.103422_bib0073","doi-asserted-by":"crossref","first-page":"414","DOI":"10.4103\/ijph.ijph_1728_21","article-title":"Precision medicine in public health in India: Nascent but poised in the right direction","volume":"65","author":"Yadav","year":"2021","journal-title":"Indian J Public Health"},{"issue":"5","key":"10.1016\/j.cpcardiol.2026.103422_bib0074","doi-asserted-by":"crossref","first-page":"555","DOI":"10.3390\/pharmaceutics17050555","article-title":"Transforming pharmacogenomics and CRISPR gene editing with the power of artificial intelligence for precision medicine","volume":"17","author":"Srivastav","year":"2025","journal-title":"Pharmaceutics"},{"issue":"4","key":"10.1016\/j.cpcardiol.2026.103422_bib0075","first-page":"297","article-title":"Current status on population genome catalogues in different countries","volume":"16","author":"Reddy","year":"2020","journal-title":"Bioinformation"},{"key":"10.1016\/j.cpcardiol.2026.103422_bib0076","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2022.858345","article-title":"Comprehensive assessment of indian variations in the druggable kinome landscape highlights distinct insights at the sequence, structure and pharmacogenomic stratum","volume":"13","author":"Panda","year":"2022","journal-title":"Front Pharmacol"},{"issue":"1","key":"10.1016\/j.cpcardiol.2026.103422_bib0077","doi-asserted-by":"crossref","first-page":"13","DOI":"10.4103\/aam.aam_13_25","article-title":"Ethical, Social, and legal issues related to precision medicine in india: challenges and solutions","volume":"25","author":"Tripura","year":"2026","journal-title":"Ann Afr Med"},{"issue":"3","key":"10.1016\/j.cpcardiol.2026.103422_bib0078","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1016\/j.mjafi.2021.06.020","article-title":"Precision medicine: Uses and challenges","volume":"77","author":"Naithani","year":"2021","journal-title":"Med J Armed Forces India"},{"issue":"2","key":"10.1016\/j.cpcardiol.2026.103422_bib0079","doi-asserted-by":"crossref","DOI":"10.1038\/s41397-024-00326-1","article-title":"A review of real-world evidence on preemptive pharmacogenomic testing for preventing adverse drug reactions: a reality for future health care","volume":"24","author":"Chenchula","year":"2024","journal-title":"Pharmacogenomics J"},{"issue":"11","key":"10.1016\/j.cpcardiol.2026.103422_bib0080","doi-asserted-by":"crossref","first-page":"950","DOI":"10.1310\/hpj5111-950","article-title":"Precision medicine: considerable potential combined with important challenges","volume":"51","author":"Fox","year":"2016","journal-title":"Hosp Pharm"},{"issue":"1","key":"10.1016\/j.cpcardiol.2026.103422_bib0081","doi-asserted-by":"crossref","DOI":"10.1186\/s40246-025-00761-6","article-title":"Advancing translational exposomics: bridging genome, exposome and personalized medicine","volume":"19","author":"Sarigiannis","year":"2025","journal-title":"Hum Genom"},{"key":"10.1016\/j.cpcardiol.2026.103422_bib0082","doi-asserted-by":"crossref","DOI":"10.1016\/j.envint.2024.109233","article-title":"Precision environmental health: Establishing the role of environmental exposures in personalized medicine for oncology","volume":"195","author":"Hamilton","year":"2025","journal-title":"Env Int"},{"issue":"6","key":"10.1016\/j.cpcardiol.2026.103422_bib0083","doi-asserted-by":"crossref","first-page":"952","DOI":"10.1016\/j.fertnstert.2018.05.006","article-title":"Personalized medicine: motivation, challenges and progress","volume":"109","author":"Goetz","year":"2018","journal-title":"Fertil Steril"},{"issue":"1","key":"10.1016\/j.cpcardiol.2026.103422_bib0084","first-page":"2449","article-title":"A precision environmental health approach to prevention of human disease","volume":"14","author":"Baccarelli","year":"2023","journal-title":"Nat Commun 2023 14:1"},{"key":"10.1016\/j.cpcardiol.2026.103422_bib0085","doi-asserted-by":"crossref","DOI":"10.1016\/j.envint.2024.108930","article-title":"Integrating multi-omics with environmental data for precision health: a novel analytic framework and case study on prenatal mercury induced childhood fatty liver disease","volume":"190","author":"Goodrich","year":"2024","journal-title":"Env Int"},{"issue":"1","key":"10.1016\/j.cpcardiol.2026.103422_bib0086","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1080\/14659890802305887","article-title":"Environmental strategies for prevention of drug use and risks in clubs","volume":"14","author":"Miller","year":"2009","journal-title":"J Subst Use"},{"issue":"12","key":"10.1016\/j.cpcardiol.2026.103422_bib0087","first-page":"1191","article-title":"Pharmacogenomics: the future of personalized medicine","volume":"3","author":"Lakambare","year":"2025","journal-title":"Int J Pharm Sci"},{"issue":"2","key":"10.1016\/j.cpcardiol.2026.103422_bib0088","doi-asserted-by":"crossref","first-page":"209","DOI":"10.2174\/1389200215666140130124910","article-title":"Incorporation of pharmacogenomics into routine clinical practice: the Clinical Pharmacogenetics Implementation Consortium (CPIC) guideline development process","volume":"15","author":"Caudle","year":"2014","journal-title":"Curr Drug Metab"},{"issue":"2","key":"10.1016\/j.cpcardiol.2026.103422_bib0089","doi-asserted-by":"crossref","DOI":"10.1161\/HCG.0000000000000097","article-title":"Artificial intelligence to enhance precision medicine in cardio-oncology: a scientific statement from the american heart association","volume":"18","author":"Khera","year":"2025","journal-title":"Circ Genom Precis Med"},{"key":"10.1016\/j.cpcardiol.2026.103422_bib0090","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1007\/s11864-024-01203-6","article-title":"Precision cardio-oncology: update on omics-based diagnostic methods","volume":"25","author":"Kuang","year":"2024","journal-title":"Curr Treat Options Oncol"},{"issue":"20","key":"10.1016\/j.cpcardiol.2026.103422_bib0091","doi-asserted-by":"crossref","first-page":"2599","DOI":"10.3390\/healthcare13202599","article-title":"Healthcare management in cardio-oncology, clinical strategies and future perspectives: a narrative review","volume":"13","author":"Quagliariello","year":"2025","journal-title":"Healthcare"},{"issue":"11","key":"10.1016\/j.cpcardiol.2026.103422_bib0092","first-page":"186","article-title":"From genes to drugs: pharmacogenomic strategies for personalized therapy in Indian populations","volume":"3","author":"Tayade*","year":"2025","journal-title":"Int J Pharm Sci"},{"key":"10.1016\/j.cpcardiol.2026.103422_bib0093","doi-asserted-by":"crossref","unstructured":"Strianese O, Rizzo F, Ciccarelli M, Galasso G, D\u2019agostino Y, Salvati A, et al. Precision and Personalized medicine: how genomic approach improves the management of cardiovascular and neurodegenerative disease. Genes. 2020 Jul 1;11(7):747. doi:10.3390\/GENES11070747 PubMed PMID: 32640513.","DOI":"10.3390\/genes11070747"},{"issue":"7","key":"10.1016\/j.cpcardiol.2026.103422_bib0094","first-page":"601","article-title":"Pharmacokinetic drug-drug interaction and their implication in clinical management","volume":"18","author":"Palleria","year":"2013","journal-title":"J Res Med Sci"},{"issue":"4","key":"10.1016\/j.cpcardiol.2026.103422_bib0095","doi-asserted-by":"crossref","first-page":"263","DOI":"10.2165\/00002018-200022040-00002","article-title":"Cardiotoxicity of chemotherapeutic agents: incidence, treatment and prevention","volume":"22","author":"Lanier","year":"2000","journal-title":"Drug Saf"},{"key":"10.1016\/j.cpcardiol.2026.103422_bib0096","doi-asserted-by":"crossref","DOI":"10.3389\/fcvm.2022.991886","article-title":"Case report: Acute toxic myocardial damage caused by 5-fluorouracil-from enigma to success","volume":"9","author":"Lasica","year":"2022","journal-title":"Front Cardiovasc Med"},{"key":"10.1016\/j.cpcardiol.2026.103422_bib0097","doi-asserted-by":"crossref","DOI":"10.3389\/fgene.2023.1099541","article-title":"Pharmacogenomics and health disparities, are we helping?","volume":"14","author":"Shaaban","year":"2023","journal-title":"Front Genet"},{"issue":"2","key":"10.1016\/j.cpcardiol.2026.103422_bib0098","doi-asserted-by":"crossref","first-page":"267","DOI":"10.26650\/EurJBiol.2021.1110344","article-title":"Personalized medicine: a solution for today and tomorrow","volume":"81","author":"Dalbayrak","year":"2022","journal-title":"Eur J Biol"},{"issue":"4","key":"10.1016\/j.cpcardiol.2026.103422_bib0099","doi-asserted-by":"crossref","first-page":"866","DOI":"10.1111\/cts.13153","article-title":"Pharmacogenomic landscape of Indian population using whole genomes","volume":"15","author":"Sahana","year":"2022","journal-title":"Clin Transl Sci"},{"issue":"2","key":"10.1016\/j.cpcardiol.2026.103422_bib0100","doi-asserted-by":"crossref","first-page":"123","DOI":"10.2174\/1875692112666140908231649","article-title":"Genetic Analysis of CYP2D6 polymorphism in indian populations and its pharmacogenetic implications","volume":"12","author":"Choudhury","year":"2015","journal-title":"Curr Pharmacogenomics Pers Med"}],"container-title":["Current Problems in Cardiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0146280626001647?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0146280626001647?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,9,7]],"date-time":"2026-09-07T13:24:45Z","timestamp":1788787485000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0146280626001647"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,11]]},"references-count":100,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2026,11]]}},"alternative-id":["S0146280626001647"],"URL":"https:\/\/doi.org\/10.1016\/j.cpcardiol.2026.103422","relation":{},"ISSN":["0146-2806"],"issn-type":[{"value":"0146-2806","type":"print"}],"subject":[],"published":{"date-parts":[[2026,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Pharmacogenomic and drug interactions risk in cardio-oncology: A precision medicine perspective for India","name":"articletitle","label":"Article Title"},{"value":"Current Problems in Cardiology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cpcardiol.2026.103422","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"103422"}}